National Rosacea Society Launches ‘Rosacea Research Digest’ Newsletter

CHICAGO (June 18, 2024) — The National Rosacea Society (NRS) announced today the launch of the Rosacea Research Digest, a monthly email newsletter highlighting the latest research and news on rosacea. To subscribe, visit rosacea.org/researchdigest.

“We’re pleased to launch the Rosacea Research Digest to help medical professionals keep up with the latest developments in rosacea, so they can provide patients with the most up-to-date care,” said Andrew Huff, president and executive director of the National Rosacea Society. “The newsletter will be a valuable resource for anyone interested in staying current on the significant research being conducted into the pathophysiology of rosacea, its treatment and comorbidities. It may also be of interest to the media and patients themselves, many of whom would like to delve deeper into the scientific side of the disease.”

The newsletter includes abstracts of recent basic and clinical research on rosacea’s pathophysiology, management and other aspects of the disease; case studies; and news from the NRS and other sources.

A complementary subscription is included as part of professional membership in the NRS, which is open to dermatologists, dermatology physician assistants and nurse practitioners, and other health professionals who treat rosacea. Subscriptions are also available free for a limited time to all health professionals, patients and others interested in this common but often misunderstood disorder affecting more than 16 million Americans.

What is Rosacea?
Rosacea is a chronic disorder of the facial skin that is often characterized by flare-ups and remissions. According to the updated standard classification of rosacea, the presence of persistent facial redness or, less commonly, phymatous changes where the facial skin thickens is considered diagnostic of the disorder. Additional major signs, which often appear with the diagnostic features, include papules (bumps) and pustules (pimples), flushing, telangiectasia (visible blood vessels) and certain ocular manifestations. The presence of two or more major features independent of the diagnostic signs is also considered diagnostic of rosacea, and secondary signs and symptoms include burning or stinging, swelling and dry appearance.

About the National Rosacea Society
The National Rosacea Society is the world's largest organization dedicated to improving the lives of the estimated 16 million Americans who suffer from this widespread but poorly understood disorder. Its mission is to raise awareness of rosacea, provide public health information on the disorder and support medical research that may lead to improvements in its management, prevention and potential cure. More information may be found at rosacea.org.

Publication Date
PR Contact
Mary Erhard / Andrew Huff